Cargando…
Prevalence of human immunodeficiency virus-1 drug-resistant mutations among adults on first- and second-line antiretroviral therapy in a resource-limited health facility in Busia County, Kenya
INTRODUCTION: in Kenya, about 1.5 million people are living with the Human Immunodeficiency Virus (HIV). Antiretroviral therapy aids in viral suppression. However, drug-resistance threaten the gains of the HIV infection control program. To determine the prevalence of HIV-1 drug-resistant mutations a...
Autores principales: | Makwaga, Olipher, Adhiambo, Maureen, Mulama, David Hughes, Muoma, John, Adungo, Ferdinard, Wanjiku, Humphrey, Ongaya, Asiko, Maitha, Geoffrey Mutisya, Mwau, Matilu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896523/ https://www.ncbi.nlm.nih.gov/pubmed/33654530 http://dx.doi.org/10.11604/pamj.2020.37.311.25909 |
Ejemplares similares
-
Burden of hypertension and associated factors among HIV-positive adults in Busia County, Kenya
por: Oyawa, Ibrahim, et al.
Publicado: (2022) -
Human immunodeficiency virus (HIV) type 1 genetic diversity in HIV positive individuals on antiretroviral therapy in a cross-sectional study conducted in Teso, Western Kenya
por: Adhiambo, Maureen, et al.
Publicado: (2021) -
Tsetse distribution, trypanosome infection rates, and small-holder livestock producers’ capacity enhancement for sustainable tsetse and trypanosomiasis control in Busia, Kenya
por: Adungo, Ferdinard, et al.
Publicado: (2020) -
Correlation of HIV-1 drug resistant mutations and virologic failure
por: Makwaga, Olipher, et al.
Publicado: (2021) -
Protocol for a Randomized Control Trial for Tungiasis Treatment in Homa Bay County, Kenya: Dimeticone versus Sodium Carbonate
por: Suzuki, Kana, et al.
Publicado: (2023)